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ABSTRACT 
Elephant endotheliotropic herpesvirus (EEHV) has been identified as the cause of rapid onset 
acute hemorrhagic disease. EEHV infects both Asian (Elephas maximus) and African 
elephants (Loxodonta africana). The virus has been detected in wild and captive populations. 
Seven different genotypes of EEHV have been identified so far. EEHV1 is recognized as the 
most common cause of acute disease, and more rarely EEHV3 and EEHV4. EEHV-associated 
disease is most common in juvenile Asian elephants. Primary infection can be either 
subclinical or cause the disease. EEHV can persist in the host in latent phase and reactivate 
from time to time. Data collection from ex situ elephants worldwide, suggest that subclinical 
EEHV1 infections are common in captivity. Subclinical infections may occur in situ also. An 
elephant with subclinical infection can shed the virus particles into a range of the host fluids. 
The infected fluids may have the potential to transmit a virus to other elephants in contact 
with the host. To be able to manage this devastating disease it is essential to identify animals 
with subclinical or latent infections. It is also critical to diagnose animals with acute disease 
immediately after the first symptoms appear. Reliable, specific, fast and easy to use diagnostic 
tools are much needed. Currently available diagnostic tools and new possible methods such as 
quantitative real-time PCR, antibody based detection, acute phase protein expression, viral 
microRNA detection and ultrasound-guided biopsy sampling are described in this review. 
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SAMMANFATTNING 
Endotheliotropiskt herpesvirus (EEHV) hos elefant har påvisats som orsak till en snabbt 
uppkommande akut hemorragisk sjukdom. EEHV infekterar både asiatiska (Elephas 
maximus) och afrikanska (Loxodonta africana) elefanter. Viruset har påvisats både hos 
elefanter i det vilda och i fångenskap. Idag har sju olika genotyper av EEHV identifierats. 
EEHV1 är den vanligaste orsaken till akut sjukdom medan EEHV3 och EEHV4 orsakar detta 
mer sällan. EEHV-associerad sjukdom är vanligast hos juvenila asiatiska elefanter. Den 
primära infektionen kan antingen vara subklinisk eller orsaka sjukdom. EEHV kan kvarstå i 
värden i en latent fas och kan återaktiveras vid olika tillfällen. Tester av elefanter från olika 
platser visar att subkliniska EEHV1-infektioner är vanliga i fångenskap men subkliniska 
infektioner har också inträffat i det vilda. En elefant med subklinisk infektion kan utsöndra 
viruspartiklarna till ett antal olika kroppsvätskor och sprida virus till andra elefanter som 
kommer i kontakt med värden. För att kunna hantera denna förödande sjukdom är det viktigt 
att identifiera djur med subkliniska eller latenta infektioner. Det är också viktigt att 
diagnosticera patienter med akut sjukdom omedelbart efter att de första symptomen 
uppkommer. Det finns ett stort behov av säkra, specifika, snabba och användarvänliga 
diagnostiska metoder. För närvarande tillgängliga diagnostiska metoder och nya tänkbara 
diagnostiska metoder såsom kvantitativ realtids-PCR, antikroppsbaserad detektion, 
akutfasprotein uttryck, viral mikroRNA detektering och ultraljud guidad biopsi provtagning 
beskrivs i detta arbete. 
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INTRODUCTION 
Over 90 cases of suspected elephant endotheliotropic herpesvirus (EEHV)-associated 
hemorrhagic diseases have been reported in elephants worldwide, of which at least 57 cases 
have been confirmed with DNA PCR diagnostics to involve EEHV infection (Fickel et al., 
2001, Garner et al., 2009, Ossent et al., 1990, Richman et al., 1999, 2000 and 2014, 
Zacharian et al., 2008). EEHV-associated hemorrhagic disease has rapid pathogenesis and a 
high fatality rate of about 80% (Hardman et al., 2012, Hayward, 2012). Disease is most 
common in young, captive-born Asian elephants (Elephas maximus). Deaths due to EEHV-
associated disease cover approximately 65% of the overall mortality rate of captive-born 
Asian elephants in North America (Hayward, 2012).  
 
Over the last 15 years, several diagnostic tools have been developed to detect active EEHV 
infections in elephants (Humphreys et al., 2015, Latimer et al., 2011, Stanton et al., 2010, 
2012 and 2014, Zacharian et al., 2013). Diagnostic real-time quantitative PCR (qPCR) sets 
have been developed and have been evaluated to be sensitive and specific to detect various 
genotypes and subgenotypes of EEHV (Stanton et al., 2012). EEHV have been detected from 
elephant whole blood, tissue samples, conjunctival swabs, palate, vaginal mucosa, urine, and 
trunk secretion (Hardman et al., 2012, Shaftenaar et al., 2010, Stanton et al., 2013a and 2014, 
Zachariah et al., 2013). Attempts to develop diagnostic tools that identify EEHV carriers with 
latent infection have also been made. Possibilities of using antibody responses, microRNA 
detection, and lymph node biopsy samples have been explored (Furuse et al., 2014, Gao et al., 
1999, Hildebrand et al., 2005, Kania et al., 1997, Kelly et al., 1998, Speckner et al., 1999, 
Stanton et al., 2012).    
 
The following paper reviews different diagnostic approaches to identify EEHV infected 
individuals and the epidemiology and transmission of this virus.  
 
MATERIALS AND METHODS 
Pub Med and Web Of Sciences databases were used to search articles. 
 
Example of search phrase:  
 (EEHV OR Elephant endotheliotropic herpesvirus OR Elephant herpesvirus OR Elephant 
gammaherpesvirus)  
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LITERATURE REVIEW 
Asian and African elephant (Loxodonta africana) are both on the International Union of 
Nature’s (IUCN) Red List of endangered species. EEHV associated disease is devastatingly 
severe and survival of these charismatic animals is under extreme pressure in both wild range 
countries and in captivity (Hayward, 2012, Zachariah et al., 2013). 
 
Herpesvirus in Asian and African elephants 
Herpesviruses 
Herpesviruses are double-stranded DNA (dsDNA) viruses classified in Baltimore's class I. 
Over 100 herpesviruses have been identified to belong in the order of Herpesviriadae. A 
notable characteristic of herpesviruses is the ability to persist in the infected host, often in 
latent form, and reactivate from time to time. Both reactivated and primary infections can be 
either asymptomatic or result in disease (Carter and Saunders, 2013). Herpesviruses have 
among the largest and most variable of all DNA genomes and are overall among the most 
extensively studied large DNA viruses (McGeoch et al., 2006, Richman et al. 2014). Detailed 
analysis of capsid structures has provided strong evidence of a common ancestor for the group 
containing herpesviruses naturally hosted by mammals, birds and reptiles (McGeoch et al., 
2006).   
 
The viral replication cycle 
Herpesvirus particles have large numbers of proteins organized into three structures: capsid, 
tegument, and envelope. The genome is a linear dsDNA molecule, which both strands are 
used for coding. The genome is housed in the icosahedral, enveloped capsid. Depending on 
the cell type, infection can occur by endocytosis or virion envelope fuses with plasma 
membrane. After virion reaches the cytoplasm some tegument proteins are released. Others 
teguments stay associated with the nucleocapsid to be transported via microtubules into the 
nucleus, where the virus replication takes place (Carter and Saunders, 2013). 
 
Herpesvirus genes are expressed in three phases: immediate early (IE), early (E), and late 
phase (L). IE genes promote transcription of E and L genes and protect the virus from the host 
immunity. Early viral mRNA is transcribed by host polymerase II, encoding E proteins that 
are essential for virus DNA replication. It is believed that the first round of circular genome 
amplification occurs via bidirectional replication and later switches to rolling circle 
replication mode. L proteins are used to form the capsid and accumulate in the nuclear 
replication compartments (Carter and Saunders, 2013). 
 
During assembly, DNA is packed first into procapsid and then nucleocapsid is constructed. 
Nucleocapsid acquires its teguments and host-derived envelope and is then released from the 
cell. Virus glycoproteins are expressed on the infected cells surface and can fuse infected cells 
with non-infected cells. This can result in giant cells known as syncytia, and are observed in 
herpes lesions (Carter and Saunders, 2013). 
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Viral latency 
Latent herpesvirus infection results when virus genome is maintained in the host nucleus 
without productivity. For most herpesviruses multiple copies of the genome stay in circular 
formation in the nucleus, but some herpesviruses get their genome integrated into the host 
chromosome. Most of the virus genome is switched off during the latent period, but a few 
regions are transcribed into RNA and some viruses synthesize a few proteins. If the host cell 
is a neuron it does not divide and no proteins are required to maintain the latency in the cell. 
In the neuron some RNA is synthesized, known as latency-associated transcripts (LATs). 
LATs give rise to two shorter LATs and microRNAs, which participate in inhibition of 
apoptosis so the neuron survives. If the host cell does divide, proteins are needed to maintain 
the copy number of the virus genome in new cells and proteins are synthesized. Latent 
herpesvirus can reactivate with increased likelihood if the host becomes immunocompromised 
(Carter and Saunders, 2013). 
 
Elephant endotheliotropic herpesvirus 
Viral genomic DNA of EEHV is well studied despite the fact that EEHV has not yet been 
grown successfully in cell culture. The complete genome sequence of two subgenotypes 
EEHV1A, EEHV1B and genotype EEHV5 have been completely resolved (Wilkie et al., 
2013, Wilkie et al., 2014). Seven distinct EEHV genotypes have been identified based on 
viral DNA sequences analysis. EEHV2, EEHV3, EEHV4, EEHV5, and EEHV6 differ 15-
35% on the nucleotide level in several genes and from each other by 8-35% (Latimer et al., 
2011, Richman and Hayward 2011, Stanton et al., 2012). EEHV1A and EEHV1B are 
complex partially related chimeric subspecies, which differ greatly in two non-adjacent loci 
but are largely very similar (Ehlers et al., 2001, 2006, Ficker et al., 2001). 
 
Until the recent, EEHVs have been classified in the genus Proboscivirus, subfamily of 
Betaherpesvirinae, family Herpesviridae, order Herpesvirales. Richman et al. (2014) 
suggested that EEHV1A, EEHV1B and EEHV2 are so highly diverged from the other 
mammalian herpesviruses that they may form a new subfamily of Deltaherpesvirinae. Five 
elephant gammaherpesviruses (EGHVs) from the subfamily of Gammaherpesvirinae have 
been reported; EGHV1-5, and subgenotypes EGHV3A and EGHV3B (Latimer et al., 2011, 
Wellehan et al., 2008). EGHVs have been detected from vaginal and conjunctival swabs of 
asymptomatic Asian and African elephants, but none have yet been suspected of contributing 
to systemic disease (Ehlers et al., 2008, Latimer et al., 2011).    
  
Disease 
EEHV-associated disease ranges in spectrum from subclinical infection to rapidly fatal 
hemorrhagic disease (Richman et al., 1999). It is believed that EEHV, like many viruses in 
the family of Herpesviridae, has the ability to cause mild asymptomatic or systemic primary 
infection and then persist in a quiescent latent phase. Latent infection occasionally reactivates 
as localized skin or mucosal epithelial lesions with active lytic infection (Carter and Saunders, 
2013, Stanton et al., 2010). 
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In systemic disease EEHV causes rapid and extensive damage to endothelial cells and often 
results in per-acute or acute death (Richman et al., 1999). The disease has very rapid onset 
and is especially serious in young captive Asian elephants (Richman et al., 1999 and 2000, 
Garner et al., 2009). Studies of the asymptomatic elephants have shown subclinical EEHV1, 
EEHV3, EEHV4, EEHV5 infections among Asian elephants and EEHV2, EEHV3, EEHV6 
and EEHV7 infections in African elephants. These EEHVs can be detected in whole blood, 
serum, tissue samples, conjunctival swabs, palate, vaginal mucosa swabs, trunk secretion and 
urine. This suggests that elephants can be persistently infected with these EEHV subtypes 
(Shaftenaar et al., 2010, Hardman et al., 2012, Zachariah et al., 2013, Stanton et al., 2013a 
and 2014).  
 
It has been suggested that EEHV1, like other known betaherpesviruses, may infect a subset of 
leukocytes and becomes detectable in whole blood. Subsequently, active viral replication has 
been shown to persist for at least several weeks in some cell type involved in producing nasal 
secretions before presumably establishing long-term quiescent latency (Stanton et al., 2013b). 
It is not known in which cells and where the EEHV rests in latent form. The mouth is a 
presumed site of infection and it has been hypothesized that lymph node draining the mouth 
could be a possible location. However, the attempt to detect latent EEHVs has not yet been 
successful (Hildebrand et al., 2005). 
 
Fatality 
EEHVs cause lethal hemorrhagic disease in both Asian and African elephants (Ehler et al., 
2001, Fickel et al., 2001, Garner et al., 2009, Ossent et al., 1990, Richman et al., 1999), but 
appear to be more pathogenic in Asian elephants (Fickel et al., 2001, Hardman et al., 2012). 
EEHV-associated disease has a mortality rate of about 80% in the nearly 90 known infections 
in Asian elephants that have been reported over the last 20 years. The disease is especially 
severe in young animals and significant numbers of otherwise healthy captive-bred calves 
have succumbed to EEHVs (Hayward, 2012, Hardman et al., 2012). There are only three 
known cases of fatal EEHV infection in African elephants (Hayward, 2012). EEHV1A and 
EEHV1B subgenotypes have been responsible for the majority of the EEHV-associated 
deaths in Asian elephants (Garner et al., 2009, Latimer et al, 2011, Richman et al., 1999). 
EEHV3, EEHV4 and the recently reported EEHV5, are known to cause sporadic fatalities in 
young Asian elephants, and EEHV2 has been attributed to similar disease in African 
elephants (Richman et al., 1999, Stanton et al., 2014, Wilkie et al., 2014). EEHV has been 
attributed to be the cause of death in wild elephants, but the number of incidents in the wild is 
still unknown (Latimer et al., 2011, Richman et al., 1999, Stanton et al., 2014). 
 
Origin 
Subclinical presentation of EEHV, with virions detected in pulmonary lymphoid nodules and 
cutaneous papillomas, has been documented in high numbers of wild African elephants as far 
back as in the 1970’s (McCully et al., 1971). A relatively small number of EEHV-associated 
diseases have been reported in African elephants (Hayward, 2012). Therefore, it was 
originally suggested that EEHV1 is indigenous to and nonlethal in African elephants, and that 
disease in Asian elephants resulted from cross-species transmission (Richman et al., 1999).  
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However, a high level of EEHV1 subtype diversity have been recently found among Indian 
strains that matched with the strain diversity found in Europe and North America. This 
suggests that it is more likely that the Asian elephant is an ancient endogenous host of 
EEHV1, and the virus is widespread and transmitted between Asian elephant populations 
worldwide (Zacharian et al., 2013). Genotypes EEHV2 and EEHV6 have not been detected 
from the Asian elephants. The question is still open if some of the EEHV genotypes are native 
to African elephants and some to Asian elephant (Stanton et al., 2014).   
 
Transmission 
In a recent study by Stanton  (2013b), EEHV1 kinetics in viral loads have proven EEHV 
genotypes that can produce DNAemia (viral DNA within the bloodstream) are subsequently 
shed in trunk secretions for at least several weeks before presumably establishing long-term 
quiescent latency. The actual pathogenesis of the infection and the nature of EEHV1 
persistence, latency and reactivation remain to be determined. The actual transmission action 
is suspected to only happen through contact of the trunk with genitals and then with the mouth 
most likely during greeting ceremonies (Hildebrandt et al., 2005, Stanton et al. 2013b).  
 
Multiple infections 
There is evidence that one individual elephant can acquire multiple EEHV infections, 
suggesting that prior infection with another EEHV subtype does not confer sterilizing 
immunity against another EEHV subtype (Stanton et al. 2013b, Richman 2014). In several 
cases, elephants have been showing evidence of both EEHV1A and EEHV1B subgenotypes, 
but have not been observed to be simultaneously infected or shedding the two. It seemed that 
the first subtype was cleared to undetectable levels in blood and nasal secretions before 
detection of a new infection episode with the second subtype (Stanton et al. 2013b). 
 
Little is known about the pathogenicity of the EEHV and there is a possibility that multiple 
EEHV infections and EGHV infections can be an underlying cause resulting in the disease 
(Latimer et al., 2011). Likely multiple host factors are playing a role including age of 
exposure, maternal antibodies during gestation or nursing, latent infections and preexisting 
presence of immunocompromising disease states (Stanton et al., 2010). Whether preexisting 
infection with another EEHV confers enough immunity to prevent fatal disease is not yet 
known (Stanton et al. 2013b). 
 
Treatment 
EEHV-associated hemorrhagic disease is treated with herpesvirus specific antiviral 
medication famciclovir or ganciclovir (Richman et al., 2000, Brock et al., 2002). Famciclovir 
is a prodrug that is rapidly deacetylated and oxidated to active form penciclovir. Penciclovir 
and ganciclovir are acyclic nucleoside analogues, which target viral DNA polymerase (Brock 
et al., 2002). Famciclovir can be administered rectally or orally being effectively absorbed 
and have similar extents of exposure. A dose of 8 to 15 mg of famciclovir/kg every 8 hours 
for the treatment of Asian elephants is recommended (Brock et al., 2002). To be able to 
interact with viral DNA synthesis penciclovir and ganciclovir need to be phosphorylated 
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intracellularly to the triphosphate form. The phosphorylation step is ensured by herpesvirus 
encoded kinase, and is therefore confined to virus-infected cells. This explains the specific 
antiherpetic ability of the compounds. Nucleoside analogue in its triphosphate form interact 
with viral DNA polymerase as a chain terminator and inhibits viral DNA synthesis (Brock et 
al., 2002). There are only 10 known Asian elephants that survived the symptomatic diseased, 
which were all treated aggressively with antiviral drugs, although such treatments were not 
effective in many other cases (Hayward, 2012).  
   
Clinical symptoms 
Systemic disease 
The systemic disease attributed to EEHV has a sudden onset of an acute hemorrhagic disease 
(Richman et al., 1999; Stanton et al., 2014). The clinical course may last from one to seven 
days and initial clinical signs include lethargy, anorexia, mild colic, and edema of the head 
and thoracic limbs. In the later course of the disease, swelling and cyanosis of the tongue is 
noted (Richman et al., 2000). EEHV viral DNA can be detected in the peripheral blood with a 
typical viral load of 10
4
 viral genomic copies (VGCs) per ml of whole blood when the clinical 
signs start (Stanton et al., 2010). Haematological changes include decreased white blood cell 
and platelet count (Richman et al., 1999). Symptoms such as limb stiffness or lameness and 
non-endothelial, cutaneous lesions are also possible (Ossent et al., 1990, Schaftenaar et al., 
2009). Untreated systemic disease ultimately leads to a myocardial failure and death 
(Richman et al. 1999, Richman et al., 2000). 
 
Nonfatal clinical presentation  
EEHVs have been isolated from skin papillomas, vestibular lymphoid patches and pulmonary 
nodules of otherwise healthy Asian and African elephants that were not exhibiting systemic 
disease (McCully et al., 1971, Richman et al., 1999, Schaftenaar et al., 2009). Transmission 
from these active lesions to susceptible elephant could easily occur, and possibly cause either 
asymptomatic infection or systemic disease for new hosts (Schaftenaar et al., 2009). 
 
Pathological findings 
Pathological findings in fatal cases associated with EEHV genotypes that are recognized 
today are typically similar, consisting of extensive edema, effusions, and hemorrhages. 
However, in EEHV1 fatal cases the primary appearance site has been the cardiovascular 
system and recent cases of EEHV3, EEHV4 and EEHV5 have suggested less selective organ 
tropism (Garner et al., 2009).  
 
Tropism 
EEHV3 infection has been related to renal medullary hemorrhage, retinal damage, and 
tropism for larger veins and arteries (Garner et al., 2009). EEHV4 has demonstrated 
hemorrhages in most organs, including gastrointestinal, respiratory, and cardiovascular 
systems (Sripiboon et al., 2013). Widespread hemorrhages and edema have been found in the 
EEHV5 case and it has been suggested that EEHV3, EEHV4 and EEHV5 might reflect higher 
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virulence of the strain involved (Garner et al., 2009, Sripiboon et al., 2013, Wilkie et al., 
2014).  
 
Gross findings 
Typical gross findings are pericardial effusion with extensive petechial to ecchymotic 
hemorrhages involving the epi- and endocardial heart surface and throughout the 
myocardium. All of the visceral and parietal peritoneal serous membranes are with scattered 
petechiae. Hepatomegaly, and variable cyanosis of the tongue, oral, laryngeal and large 
intestinal ulcers can be found (Richman et al., 2000). 
 
Histological findings 
Histological findings include extensive micro-hemorrhages and edema throughout the 
myocardium and mild subacute myocarditis. Hemorrhagic lesions with inflammation have 
been found in the target organs and were accompanied by amphophilic to basophilic 
intranuclear inclusion bodies in capillary endothelial cells (Richman et al., 2000). EEHV 
inclusion bodies have been detected in the heart, lungs, and liver and in the case of EEHV5 
also in the adrenal gland and oral mucosa (Garner et al., 2009, Wilkie et al., 2014). High 
levels of viral DNA are found in white blood cells, serum, and necropsy tissues (Latimer et 
al., 2011).  
 
Diagnostics  
Quantitative real-time PCR 
There have been several reports on polymerase chain reaction (PCR) based methods 
developed to detect viral DNA in varied fluid and histological samples (Fickel et al., 2001 
and 2003, Garner et al., 2009, Schaftenaar et al., 2009, Hardman et al., 2012, Latimer et al., 
2011, Sariya et al., 2012, Stanton et al., 2010 and 2014). Viral DNA can be detected before 
the onset of clinical illness and peak in whole-blood viral loads occur 3-8 days after the onset 
of clinical signs (Stanton et al., 2013b). 
 
Sample collection and preparation 
Trunk-wash samples can be collected by means of the standard recommended technique for 
collection of samples for Mycobacterium tuberculosis testing by the USDA. Sterile saline 
solution is poured to the nares of the elephant, and the proboscis is elevated for about half a 
minute, after which the elephant blows the effluent to a container (Stanton et al., 2010). The 
sample is then centrifuged into a cell pellet, which is processed with a commercial kit to 
extract the DNA (Stanton et al., 2010, Hardman et al., 2012).  
 
Swab samples collected from the trunk can be stored in viral transport medium (VTM) that 
can be supplemented with gelatin and antibiotics (Sariya et al., 2012). Swab samples from 
conjunctiva, palate and vulva can be collected by using swabs moistened with phosphate 
buffer solution or sterile saline and later soaked in phosphate buffer solution (Hardman et al., 
2012). In the laboratory, swab samples are centrifuged and stirred. The swab is removed and 
centrifugation is repeated. The cell pellet is then processed with a commercial kit (Sariya et 
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al., 2012). When processing tissue- and whole blood samples DNA is extracted by using a 
commercial kit to receive first a cell pellet and then extracted DNA (Stanton et al., 2010).  
 
DNA amplification 
The extracted DNA from the pellets can then be quantified with a spectrophotometer. 
Samples are used either directly or amplified by using a commercial kit before being 
subjected to the real-time PCR (Hardman et al., 2012). 
  
qPCR assays 
Primers and probes that are designed for published sequences of EEHVs are available in the 
GenBank with accession numbers (NAPs) (Hardman et al., 2012, Stanton et al., 2010). 
Sensitive qPCR assays have been developed for EEHV1A and 1B, EEHV2, 3, 4, 5, and 6 
(Stanton et al., 2012). Asian elephant tumor necrosis factor alpha (TNF) assay can be 
included to the PCR run to detect Asian elephant genomic DNA. It can be used as an internal 
PCR amplification control to determine if taken samples do contain amplifiable elephant 
genomic DNA (Stanton et al., 2010 and 2012). 
 
Reliability  
It has been shown that available EEHV sequence-specific hydrolysis probes are highly 
specific, and the chance of amplifying  non-EEHV nucleic acids is likely small (Stanton et al., 
2014). QPCR assays designed to recognize specific sequence in either the DNA polymerase 
gene or the terminase gene for EEHV2-6 types have been proven to have high specificity, 
sensitivity and reproductive ability. The only assay that has exhibited cross-reactivity between 
different EEHV species has been EEHV3/4 assay. Therefore a single qPCR assay is used to 
detect EEHV3/4. Reasons for cross-reactivity are the high DNA sequence similarity between 
EEHV3 and EEHV4 amplicon sequences and the primer design used. EEHV3 and EEHV4 
have 100% identical terminase gene (Stanton et al., 2012).  
 
Developed EEHV qPCR assay has been shown to be reliable detecting virus DNA in a wide 
variety of selected samples including tissue taken from necropsy and blood from symptomatic 
animals as well as trunk washes or blood samples from the asymptomatic animals (Stanton et 
al., 2010 and 2014). In Hardman et al. (2012) swab samples collected from conjunctiva, 
palate, and vulva were compared with trunk wash samples. EEHV1 was detected at the 
highest rate from the conjunctival swabs. The result does not correlate with Stanton et al. 
(2014), which did not detect any EEHV’s from conjunctival swab samples. It is possible that 
this may be a result from different DNA purification methods, QPCR assays, and qPCR 
reagents that were used (Stanton et al., 2014). 
 
Antibody-based detection 
Ehlers et al. (2001) have identified a glycoprotein B (gB) gene in EEHV1. GB is a major 
herpesviral envelope protein known to induce a neutralizing antibody response in herpesvirus 
infections (Gao et al., 1999, Speckner et al., 1999). In a recent study, Humphreys et al. (2015) 
were not able to express gB homolog but instead achieved robust expression of another 
surface glycoprotein L (gL). First generation enzyme-linked immunosorbent (ELISA) assay 
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was set up to detect anti-EEHV1 gL antibodies from elephants that were known to be 
previously infected with EEHV1, and relatively constant positive titers were achieved 
(Humphreys et al., 2015).  
 
Three elephant immunoglobulin isotypes have been detected so far; immunoglobulin G (IgG) 
(Kania et al., 1997, Kelly et al., 1998) in both Asian and African elephants and 
immunoglobulin A (IgA) and M (IgM) in Asian elephants (Humphreys et al., 2015). Specific 
antisera reactive against IgA and IgM isotypes, and monoclonal antibody against Asian 
elephant IgG have been generated. All three immunoglobulin isotypes can be detected in 
Asian elephant serum and milk. These reagents might be useful in the future for developing 
sensitive and specific assays to detect elephant antibody responses for EEHV and other 
pathogens or possibly even vaccines (Humphreys et al., 2015).   
 
Acute phase protein expression 
The acute phase response acts as a major part in inflammatory response and is mediated by 
acute phase proteins (APP). Serum amyloid A (SAA) has been identified as a major APP in 
elephants (Stanton et al., 2013a). Infection, inflammation, stress, neoplasia and trauma can 
give rise to APPs, which are synthesized within 24 hours of the stimuli and can increase in 
magnitude rapidly (Kjelgaard-Hansen et al., 2003, Crey et al., 2009 and 2011). It has been 
demonstrated that SAA levels from elephants with EEHV1 viremia are significantly 
increased, but APPs are nonspecific biomarkers with a short half-life (Kjelgaard-Hansen et 
al., 2003, Stanton et al., 2013a). At the moment SAA levels have potential in health 
examinations of elephants or for establishing a prognosis upon infection of EEHV (Stanton el 
al., 2012).   
 
Viral microRNA detection 
MicroRNAs (miRNA) are regulatory RNAs which post-transcriptionally down-regulate the 
expression of target mRNAs (Bartel, 2009). Many herpesviruses, including many in hte 
Betaherpesvirinae family are known to encode viral miRNAs, which are often expressed at 
very high levels and released to the serum (Cullen, 2009). It has been demonstrated that 
EEHV1 expresses at least three novel viral miRNAs of which miR-E3-5P was shown to be 
functional and expressed at high levels in the infected cells. MiR-E3-5P has been detected 
from a whole blood sample of an EEHV1 positive elephant by using miR-E3-5P specific 
TaqMan probe. It is possible that miR-E3-5p is also released into the circulation of animals 
that are asymptomatically infected with EEHV1 and can be used as a biomarker if the level is 
high enough to be detected (Furuse et al., 2014). 
  
Ultrasound-guided biopsy 
Biopsy samples from lymphoid tissue appears to be one option for detecting latently EEHV 
infected lymphocytes. Hildebrand et al. (2005) have identified a lateral retropharyngeal 
lymph node in elephants, that collects lymphatic drainage from the mouth, specifically from 
the salivary gland, gingiva and tongue, which are presumed to be initial site of EEHV 
infection (Hildebrand et al., 2005).  
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Ultrasound-guided, fine-needle biopsy sampling has been successfully completed for 
elephants. Active, inactive and chronically active lymph tissues were identified, but no EEHV 
DNA or occlusion bodies were found. Reactivity status can provide information about overall 
health status of the elephant but is unspecific about the cause of activation. It is possible that a 
lymph node biopsy procedure may prove beneficial in the future and the retropharyngeal 
lymph node can be a site of latent EEHVs (Hildebrand et al., 2005) 
 
DISCUSSION 
The overall prevalence of EEHV infection in elephants throughout the world is still not 
known but is expected to be high (Stanton et al., 2014). What is notable is that routine 
investigations, in captive populations in particular, focus on the detection of EEHV1 and tend 
to neglect other genotypes (Wilkie et al., 2014). If only EEHV1 is tested, it is possible that the 
lower fatality reports associated with other genotypes do not necessarily indicate lower 
prevalence of these viruses, but are due to the appearance of virulent variants. There are 
apparent occurrences of a recombination between EEHV1 subgenotypes. A recombination 
could render divisions of other EEHV genotypes to subgenotypes. This would be problematic 
with PCR assays that are based on different gene forms from known EEHVs (Wilkie et al., 
2014). 
 
A difficult management issue for EEHV-associated disease is its rapid progression and short 
time frame between appearance of clinical signs and death, which leaves little time for 
diagnostics (Ossent et al., 1990). Detection of latent carriers would help caretakers prevent 
infection of naïve animals and identify animals with a need for regular monitoring. Regular 
monitoring would lead to earlier disease diagnosis in cases of EEHV reactivation and 
treatment could begin on time. QPCR diagnostic assays are the most used method in practice 
and can detect EEHV viral DNA from several different kinds of fluid samples. An issue with 
EEHV viral DNA detection from the body fluids is that EEHV has to be in an active stage 
(Stanton et al., 2012). 
 
Recently generated first generation gL ELISA assay was able to detect anti-EEHV1 
antibodies from a serum sample of Asian elephants (Humphreays et al., 2015). This gL 
ELISA assay could be a potential diagnostic tool for identifying the asymptomatic and latent 
carrier elephants that have been exposed to EEHV1. It appears as a most promising diagnostic 
tool for the future to perform infection monitoring and epidemiological studies. Antibody 
assay would also be valuable for evaluating potential treatments or vaccines against EEHV 
infection.  
 
Another diagnostics method with potential to detect latent carriers in the future is miRNA 
expression detection. Furuse et al. (2014) were able to identify one functional EEHV1 
miRNA (miR-E3-5p) and two other possible EEHV1 miRNA, from whole blood and several 
tissue samples of EEHV1 infected elephants. MiRNAs expression in the elephants have not 
yet been studied extensively, but it is possible that viral miRNAs could target the same 
mRNAs that are targeted by cellular miRNA and be expressed during the viral latency. It is 
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unlikely that they represent targets for intervention in EEHV-associated disease, but MiRNAs 
might have the potential to serve as biomarkers in diagnostics (Furuse et al., 2014).  
 
Lymph node biopsy procedures may prove beneficial in the future for screening diseases in 
elephants. In vivo assessment and biopsy of the lymph nodes are standard procedures in 
domestic animals. Many disease processes are diagnosed and evaluated by the examination of 
lymph nodes (Hildebrant et al., 2005). Previously, only few lymph nodes had been identified 
from the elephant. The retropharyngeal lymph node that Hildebrand et al. (2005) identified 
from the elephant is now known to be accessible in vivo. It was stated that guidance of the 
ultrasound in the procedure is essential, since the lymph node cannot be palpated or visualized 
externally. There is also a risk of puncturing the associated blood vessel causing 
uncontrollable bleeding, if the area is not visual (Hildebrand et al., 2005). Biopsy collection is 
a difficult procedure, especially in the wild, and fast reliable detection methods are much 
needed for control of the EEHVs.  
 
Collection of conjunctival swabs have been found to be less difficult than collection of trunk 
washes, suggesting that optimization of EEHV screening using conjunctival or other mucosal 
swabs would be useful especially for screening of non-trained animals (Stanton et al., 2014). 
Additional diagnostic assays designed for swab samples and serological anti-EEHV antibody 
assays for all EEHV genotypes would make routine monitoring of the animals remarkably 
easier. Recent study results have been encouraging and these tools may be available in the 
near future (Humphreys et al., 2015).   
 
There is a lack of knowledge about the conditions under which EEHVs cause fatal 
hemorrhagic disease and the conditions in which latent infections are reactivated. 
Herpeviruses in general tend to get reactivated from the latent phase more likely if the host 
becomes immunocompromised (Carter and Sounder, 2013). In pathological examinations 
from EEHV deceased elephants no evidence of other underlying diseases or infections have 
been found and cross reactivity with other herpesviruses has not been detected (Ossent et al., 
1999, Richman et al., 2000). Hypovitaminosis E have been considered as a differential 
diagnosis of several elephants due to ecchymotic hemorrhages that were documented at 
necropsy of several elephants, but low vitamin E levels have not been found (Richman et al., 
2000). Co-infections with gammaherpesviruses and several EEHV subtypes have been 
reported, but the underlying cause remains speculative (Wilkie et al., 2014).  
 
A long-term solution for captive elephants will most likely be the development of adapted 
annulated live or killed EEHV vaccines. Vaccine development is challenged by the inability 
to grow any EEHVs in cell culture and also a very large number of different EEHV 
genotypes.  
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